MAP7D3 and cancer: Knockdown of MAP7D3 expression effectively suppressed in vitro metastasis traits of highly metastatic TNBC cells including cancer cell migration, invasion, and anchorage-independent growth (Fig. 2) and sensitized TNBC cells to standard chemo drug treatment such as docetaxel and gemcitabine (Fig. 3).